{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/641216df1cc77a0010101f8c/66e463602dcefcfc93df62d1?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Enzyme Blockers","description":"<p>Every hero needs a sidekick: Batman and Robin, the Lone Ranger and Tonto, Ronald McDonald and Grimace. And, in Parkinson's world, if Levodopa is the crime-fighting vigilante, then enzyme blockers (or inhibitors) are keeping the seats warm in the Batmobile. To discuss the vital role that this group of drugs play, the <em>Movers and Shakers</em> are joined in the pub by Professor Peter Jenner, a pharmacological expert, and Lynn Guldin, a new PhD student looking into Parkinson's treatments.</p><p><br></p><p>Presented by Rory Cellan-Jones, Gillian Lacey-Solymar, Mark Mardell, Paul Mayhew-Archer, Sir Nicholas Mostyn and Jeremy Paxman.</p><p>Produced and edited by Nick Hilton for Podot.</p><p>Sound mixing by Ewan Cameron.</p><p>Music by Alex Stobbs.</p><p>Artwork by Till Lukat.</p><p>PR by Sally Jones.</p>","author_name":"Podot"}